[ORGANIZATION]
Atlas Bio
Featured in 2 tracked stories · first seen
Situations
AI-driven drug discovery and regulatory integration
23 clusters · 65 sources · last updated
Latest: AI-driven drug discovery platforms gain momentum with new funding and technology
By late 2026, the pharmaceutical industry has transitioned from pilot programs to full-scale execution, focusing on a ‘data closed loop’ through major partnerships such as Eli Lilly and NVIDIA, and Merck & Co., Inc. with
AI development in medical and biotechnology sectors
2 clusters · 5 sources · last updated
Latest: Atlas Bio raises $12.5M to simulate drug trials using AI
Recent developments show increased investment in artificial intelligence applications for healthcare and drug development. BioStack, a healthtech startup, secured $9.5 million in seed funding to build data infrastructu